SWAN Genomics

Sydney, Australia

Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.

$317K raised

Mar 2026

Grant

Biotechnology Genetics

Top Investors

Investible Pacific Channel Proto Axiom NSW Government Australian Economic Accelerator

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SWAN Genomics

How much funding has SWAN Genomics raised?

SWAN Genomics has raised $317K in total funding. The most recent round was Grant. The last funding was announced in March 2026.

Who are SWAN Genomics's investors?

SWAN Genomics's investors include Investible, Pacific Channel, Proto Axiom, NSW Government, Australian Economic Accelerator.

Where is SWAN Genomics headquartered?

SWAN Genomics is headquartered in Sydney, Australia.

What does SWAN Genomics do?

Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.

What stage is SWAN Genomics at?

SWAN Genomics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 6, 2026.

MLA

"SWAN Genomics — Funding & Investors." VCBacked, March 6, 2026, https://www.vcbacked.co/company/swan-genomics. Accessed July 2, 2026.

APA

VCBacked. (2026). SWAN Genomics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/swan-genomics

Wikipedia (cite web)

{{cite web |title=SWAN Genomics — Funding & Investors |url=https://www.vcbacked.co/company/swan-genomics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 6, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K